Fexofenadine (Allegra® 180) is a second-generation antihistamine. It is widely used as anti-allergic drug, which suppresses various allergic reactions mediated by histamines. A few cases of H1-antihistamine-induced urticaria have been reported. Herein, we report a rare case of fexofenadine-induced urticaria which was confirmed by a prick test, oral provocation test, and flow cytometry assisted-basophil activation test.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276789 | PMC |
| http://dx.doi.org/10.5021/ad.2011.23.S3.S329 | DOI Listing |
Publication Analysis
Top Keywords
fexofenadine-induced urticaria
8
urticaria fexofenadine
4
fexofenadine allegra®
4
allegra® 180
4
180 second-generation
4
second-generation antihistamine
4
antihistamine anti-allergic
4
anti-allergic drug
4
drug suppresses
4
suppresses allergic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!